Advertisement
Screener

Avant Diagnostics, Inc Research and Development Expense (Excluding Acquired in Process Cost)

Avant Diagnostics, Inc Research and Development Expense (Excluding Acquired in Process Cost)

Avant Diagnostics, Inc reported Research and Development Expense (Excluding Acquired in Process Cost) of $25.00 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2018-08-28.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2018-08-28

  • Avant Diagnostics, Inc research and development expense (excluding acquired in process cost) for the quarter ending 2015-09-30 was $0.00.
  • Avant Diagnostics, Inc research and development expense (excluding acquired in process cost) for the quarter ending 2015-06-30 was $25.00K.
  • Avant Diagnostics, Inc research and development expense (excluding acquired in process cost) for fiscal 2015 was $25.00K.
Period endResearch and Development Expense (Excluding Acquired in Process Cost) 3 monthResearch and Development Expense (Excluding Acquired in Process Cost) 6 monthResearch and Development Expense (Excluding Acquired in Process Cost) 9 monthResearch and Development Expense (Excluding Acquired in Process Cost) 12 month
2015-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-28
$25.00K
derived: sum of 2 quarters · filed 2018-08-28
$25.00K
10-K · filed 2018-08-28
2015-06-30$25.00K
10-Q · filed 2017-09-26
$25.00K
10-Q · filed 2017-09-26